Dermatology Partnerships Safety 
The Dermatology Digest
SEPTEMBER 9, 2024
In a preliminary review by an independent data safety committee, the ongoing study of 60 patients demonstrated a much lower incidence and severity of side effects as well as improved efficacy for preventing Raynaud’s attacks, when compared to published reviews of current therapies. and Abroad appeared first on The Dermatology Digest.
The Dermatology Digest
JULY 16, 2024
SHADES was developed in partnership with the experiential designers at Makeout. Visitors will receive samples of La Roche-Posay’s Anthelios sun care products along with sun safety information. 1] [link] The post La Roche-Posay and the Edge Launch Immersive Color Exhibit in NYC appeared first on The Dermatology Digest.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Dermatology Digest
JULY 22, 2024
“This launch symbolizes the robustness of our platform, the value of our partnership with STADA, and our collective focus on the importance of biosimilars.” The post Biosimilar News: Stada, Alvotech Launch the First Ustekinumab Biosimilar Across Europe appeared first on The Dermatology Digest.
The Dermatology Digest
MAY 14, 2024
The American Skin Association’s (ASA) SPOTS (Sun Protection Outreach Teaching by Students) program will receive the inaugural 2024 Research Achievement Award in Community Education/Outreach at the upcoming 2024 Society for Investigative Dermatology (SID) Annual Meeting in Dallas, TX. We are honored to receive this award.”
The Dermatology Digest
JANUARY 30, 2024
The Pediatric Dermatology Research Alliance (PeDRA) has awarded nearly $240K to support pediatric dermatology research across four competitive grant programs. Run in partnership with NAAF, the Pediatric Alopecia Areata Challenge Grant supports research investigations focused on pediatric alopecia areata.
The Dermatology Digest
DECEMBER 20, 2023
Mr. Raducha-Grace recently served as Head of Clinical Partnerships at Harbor Health. Secondary measures of efficacy, as well as safety and pharmacokinetics, will also be assessed. Head of the SAB, Is a Professor of Dermatology with Penn State Health Hershey Medical Center, and Penn State College of Medicine. Billingsley, MD.,
The Dermatology Digest
FEBRUARY 27, 2024
This approval marks an important milestone for Teva and Alvotech’s partnership to collaborate on seven biosimilars and expand the availability, access, and uptake of biosimilars in the U.S.” The post Biosimilar News: FDA Approves Simlandi as Third Interchangeable Humira Biosimilar appeared first on The Dermatology Digest.
Expert insights. Personalized for you.
36 
Let's personalize your content